Surgery Partners, Inc.
SGRY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,670,003 | $4,018,360 | $2,561,783 | $3,868,326 |
| - Cash | $269,500 | $195,900 | $282,900 | $389,900 |
| + Debt | $3,703,400 | $3,061,600 | $2,929,700 | $3,294,500 |
| Enterprise Value | $6,103,903 | $6,884,060 | $5,208,583 | $6,772,926 |
| Revenue | $3,114,300 | $2,743,300 | $2,539,300 | $2,225,100 |
| % Growth | 13.5% | 8% | 14.1% | – |
| Gross Profit | $745,600 | $647,500 | $574,900 | $491,400 |
| % Margin | 23.9% | 23.6% | 22.6% | 22.1% |
| EBITDA | $501,400 | $446,100 | $460,000 | $401,000 |
| % Margin | 16.1% | 16.3% | 18.1% | 18% |
| Net Income | -$168,100 | -$11,900 | -$54,600 | -$70,900 |
| % Margin | -5.4% | -0.4% | -2.2% | -3.2% |
| EPS Diluted | -1.33 | -0.095 | -0.59 | -1.12 |
| % Growth | -1,304.4% | 83.9% | 47.3% | – |
| Operating Cash Flow | $300,100 | $293,800 | $158,800 | $87,100 |
| Capital Expenditures | -$90,400 | -$88,800 | -$80,600 | -$57,600 |
| Free Cash Flow | $209,700 | $205,000 | $78,200 | $29,500 |